Innovative Medicines Canada has an effective and engaged Board of Directors that enables member companies to achieve common objectives.
Ronnie Miller, Hoffmann-La Roche Limited
Al Reba, Bristol-Myers Squibb Canada
Jared Rhines, Akcea Therapeutics Canada Inc.
Jorge Bartolome, Janssen Inc.
Frédéric Fasano, Servier Canada Inc.
John Haslam, Horizon Therapeutics Canada Inc.
Alok Kanti, Bayer Inc.
Stéphane Lassignardie, AbbVie Corporation
Lisa Matar, Eli Lilly Canada Inc.
Michael Mullette, Sanofi Canada
Sylvie Pilon, Lundbeck Canada Inc.
Anna van Acker, Merck Canada Inc.